Mesa Laboratories Inc.
MLAB | NASDAQ
$134.10
+$2.23 (+1.69%)
Sep 22, 2026, 12:36 PM ET · Market open
Fiscal Year Period Ending | FY 2026 Mar 30, 2026 | FY 2025 Mar 30, 2025 | FY 2024 Mar 30, 2024 | FY 2023 Mar 30, 2023 | FY 2022 Mar 30, 2022 | FY 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|
Revenue | 249.13M | 240.98M | 216.19M | 219.08M | 184.34M | 133.94M |
Cost of Revenue | 90.86M | 90.11M | 82.94M | 85.39M | 75.25M | 46.92M |
Gross Profit | 158.27M | 150.87M | 133.25M | 133.69M | 109.09M | 87.01M |
Operating Income | 18.51M | 16.34M | -272.08M | 3.32M | 4.7M | 12.36M |
Interest Income | n/a | n/a | n/a | n/a | n/a | 107K |
Pretax Income | 12.01M | 5.96M | -275.65M | -389K | 3.57M | 2.3M |
Net Income | 6.71M | -1.97M | -254.25M | 930K | 1.87M | 3.27M |
Selling & General & Admin | 119.45M | 115.02M | 111.49M | 109.88M | 88.62M | 64.27M |
Research & Development | 20.31M | 19.52M | 19.3M | 20.49M | 15.77M | 10.39M |
Other Expenses | n/a | n/a | 274.53M | n/a | n/a | n/a |
Operating Expenses | 139.76M | 134.53M | 405.33M | 130.37M | 104.39M | 74.66M |
Interest Expense | 10.69M | 11.86M | 5.7M | 4.77M | 3.89M | 8.02M |
Selling & Marketing Expenses | 40.79M | 41.68M | 38.63M | 37.44M | 28.31M | 18.48M |
Cost & Expenses | 230.62M | 224.64M | 488.26M | 215.76M | 179.63M | 121.58M |
Income Tax Expense | 5.3M | 7.94M | -21.4M | -1.32M | 1.7M | -971K |
Shares Outstanding (Basic) | 5.51M | 5.43M | 5.39M | 5.32M | 5.21M | 4.98M |
Shares Outstanding (Diluted) | 5.57M | 5.43M | 5.39M | 5.36M | 5.34M | 5.12M |
EPS (Basic) | 1.22 | -0.36 | -47.20 | 0.17 | 0.36 | 0.66 |
EPS (Diluted) | 1.21 | -0.36 | -47.20 | 0.17 | 0.35 | 0.64 |
EBITDA | 35.29M | 42.35M | -238.38M | 37.52M | 32.53M | 27.99M |
EBIT | 12.01M | 17.82M | -269.95M | 4.38M | 7.46M | 10.33M |
Depreciation & Amortization | 23.27M | 24.53M | 31.57M | 33.13M | 25.07M | 17.66M |
Add to Watchlist
Select watchlists to add or remove MLAB